Skyward Specialty is pairing strong underwriting returns with lower costs, while Apollo is emerging as a key growth driver.

Skyward Specialty Insurance posted a strong Q2, outperforming Wall Street’s expectations on both revenue and adjusted earnings. This positive market reaction was fueled by the company’s robust premium growth across specialized segments and ongoing margin improvements. Management highlighted the benefits of its diversified business mix, particularly the expansion in Accident & Health, Credit & Surety, and Global Agriculture, as key contributors to the quarter’s performance. CEO Andrew Robinson em

Operating earnings jumped 46% as management pivots to shorter-tail niche markets.

Skyward Specialty's Q2 earnings beat estimates as premium growth accelerates, with strong contributions from Apollo and profitable underwriting.

The best-performing stocks typically have robust sales growth, increasing margins, and rising returns on capital, and those that can maintain this trifecta year in and year out often become the legends of the investing world.

Skyward Specialty Insurance Group reported its second-quarter 2026 results, with revenue rising to US$489.53 million and net income to US$49.04 million, alongside higher basic and diluted earnings per share from continuing operations versus a year earlier. The company also completed a US$9.7 million buyback of 223,000 shares, while continuing to be recognized as a sector leader following its earlier acquisition of Apollo Group Holdings. We’ll now examine how this stronger quarterly...

Skyward Specialty Insurance Group (SKWD) is back in focus after reporting second quarter results on August 4, 2026, along with a completed share repurchase tranche that together highlight recent financial and capital allocation decisions. See our latest analysis for Skyward Specialty Insurance Group. At a latest share price of $63.63, Skyward Specialty Insurance Group has given investors a 36.28% 90 day share price return and a 156.47% three year total shareholder return, which points to...

Teradyne and Credo Technology are in bases on Thursday. Skyward Specialty Insurance and NetApp also on watch.

Property and casualty insurance company Skyward Specialty Insurance Group is sustaining its place on the stringent IBD Sector Leaders list. The specialty insurance company topped second-quarter earnings estimates on Aug. 4. Skyward finalized its acquisition of Apollo Group Holdings on Jan. 2.

Skyward Specialty delivers robust Q2 with 19% operating ROE, driven by strong growth in accident and health and agriculture, while navigating challenging property market conditions.

Skyward Specialty Insurance Group (NASDAQ:SKWD) reported higher second-quarter earnings and premium volume, supported by underwriting profitability, growth in several specialty businesses and increased investment income. Chairman and Chief Executive Officer Andrew Robinson called the quarter “simpl

While the top- and bottom-line numbers for Skyward (SKWD) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Skyward (SKWD) delivered earnings and revenue surprises of +13.04% and +6.50%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Specialty insurance provider Skyward Specialty Insurance (NASDAQ:SKWD) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 53% year on year to $489.5 million. Its non-GAAP profit of $1.30 per share was 10.8% above analysts’ consensus estimates.

Specialty insurance provider Skyward Specialty Insurance (NASDAQ:SKWD) will be reporting results this Tuesday after the bell. Here’s what to expect.

SKWD heads into Q2 earnings with strong premium and investment income growth expected, while rising costs remain a key watchpoint.

Skyward (SKWD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Tuesday's IBD 50 Growth Stocks To Watch choice is an insurance company that may not immediately come to mind. Insurance stocks have been a defensive alternative as investors have rotated out of more volatile chip and artificial intelligence names. Skyward's stock formed a handle on a 59-week-long cup base.

This IBD Sector Leader and IBD 50 insurance company may not immediately come to mind. Insurance stocks have been a defensive alternative as investors have rotated out of more volatile chip and artificial intelligence names. Now, these carriers are also tapping into artificial intelligence and machine learning to help with data analytics and risk assessment.

The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the resilience and financial flexibility of large-cap firms, making careful selection crucial.

Skyward Specialty Insurance’s 25.4% return over the past six months has outpaced the S&P 500 by 17.2%, and its stock price has climbed to $58.31 per share. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.

Skyward (SKWD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.